Growth Metrics

Oncology Institute (TOI) Non-Current Deferred Tax Liability (2020 - 2025)

Historic Non-Current Deferred Tax Liability for Oncology Institute (TOI) over the last 6 years, with Q1 2025 value amounting to $32000.0.

  • Oncology Institute's Non-Current Deferred Tax Liability changed 0.0% to $32000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $32000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $32000.0 for FY2024, which is 9968.66% down from last year.
  • According to the latest figures from Q1 2025, Oncology Institute's Non-Current Deferred Tax Liability is $32000.0, which was down 0.0% from $32000.0 recorded in Q4 2024.
  • Oncology Institute's Non-Current Deferred Tax Liability's 5-year high stood at $10.2 million during Q4 2023, with a 5-year trough of $32000.0 in Q1 2024.
  • In the last 5 years, Oncology Institute's Non-Current Deferred Tax Liability had a median value of $120000.0 in 2023 and averaged $1.6 million.
  • Per our database at Business Quant, Oncology Institute's Non-Current Deferred Tax Liability surged by 32784.06% in 2022 and then plummeted by 9968.66% in 2024.
  • Over the past 5 years, Oncology Institute's Non-Current Deferred Tax Liability (Quarter) stood at $2.0 million in 2021, then soared by 327.84% to $8.7 million in 2022, then grew by 17.38% to $10.2 million in 2023, then tumbled by 99.69% to $32000.0 in 2024, then changed by 0.0% to $32000.0 in 2025.
  • Its Non-Current Deferred Tax Liability was $32000.0 in Q1 2025, compared to $32000.0 in Q4 2024 and $32000.0 in Q3 2024.